ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 56 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1 | 0.0% | 5,000 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $1 | -100.0% | 5,000 | -72.2% | 0.00% | -66.7% |
Q3 2022 | $4,000 | -55.6% | 18,000 | 0.0% | 0.00% | -57.1% |
Q2 2022 | $9,000 | -18.2% | 18,000 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $11,000 | 0.0% | 18,000 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $11,000 | -35.3% | 18,000 | 0.0% | 0.01% | -41.7% |
Q3 2021 | $17,000 | -15.0% | 18,000 | 0.0% | 0.01% | -7.7% |
Q2 2021 | $20,000 | +150.0% | 18,000 | +125.0% | 0.01% | +116.7% |
Q1 2021 | $8,000 | +100.0% | 8,000 | 0.0% | 0.01% | +100.0% |
Q4 2020 | $4,000 | +33.3% | 8,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $3,000 | -50.0% | 8,000 | 0.0% | 0.00% | -40.0% |
Q4 2019 | $6,000 | +100.0% | 8,000 | +100.0% | 0.01% | +150.0% |
Q3 2019 | $3,000 | 0.0% | 4,000 | +100.0% | 0.00% | -33.3% |
Q2 2019 | $3,000 | -25.0% | 2,000 | 0.0% | 0.00% | -25.0% |
Q1 2019 | $4,000 | -20.0% | 2,000 | 0.0% | 0.00% | -20.0% |
Q4 2018 | $5,000 | -28.6% | 2,000 | 0.0% | 0.01% | -16.7% |
Q3 2018 | $7,000 | – | 2,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROW Partners, LLC | 325,000 | $2,077,000 | 1.27% |
DAFNA Capital Management LLC | 125,000 | $799,000 | 0.82% |
BARD ASSOCIATES INC | 170,925 | $1,094,000 | 0.46% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 525,000 | $3,355,000 | 0.36% |
SOPHROSYNE CAPITAL LLC | 42,000 | $267,000 | 0.23% |
Granite Point Capital Management, L.P. | 205,000 | $1,310,000 | 0.22% |
SABBY MANAGEMENT, LLC | 407,024 | $2,601,000 | 0.17% |
SCOGGIN MANAGEMENT LP | 150,000 | $959,000 | 0.08% |
Geduld E E | 25,000 | $160,000 | 0.08% |
PRELUDE CAPITAL MANAGEMENT, LLC | 45,000 | $288,000 | 0.05% |